Zogenix International Limited, Inc. clinical trials

Acquired by UCB S.A., Mar 7, 2022 · source ↗

The registry lists 6 studies whose lead sponsor is Zogenix International Limited, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 14, 2025.

Before and after it joined UCB S.A.

First submitted before Zogenix International Limited, Inc. became part of UCB S.A.: 6
First submitted after Zogenix International Limited, Inc. became part of UCB S.A.: 0
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Completed: 5
Terminated: 1

Phase

Phase 3: 5
Phase 1: 1

Where

United States: 6
Spain: 4
Canada: 4
France: 4
Germany: 4
United Kingdom: 3

Registry sponsor names on this page

Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.6 studies

Something wrong with this grouping? Tell us on the UCB S.A. page.

Studies

Recruiting first, then most recently updated. Showing 6 of 6. All UCB S.A. studies →

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet SyndromeCompletedNCT02823145Phase 3
Sponsor listed in the registry: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. · First submitted before Zogenix International Limited, Inc. became part of UCB S.A.
A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut SyndromeCompletedNCT03355209Phase 3
Sponsor listed in the registry: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. · First submitted before Zogenix International Limited, Inc. became part of UCB S.A.
A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking CannabidiolCompletedNCT03467113Phase 1
Sponsor listed in the registry: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. · First submitted before Zogenix International Limited, Inc. became part of UCB S.A.
A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet SyndromeTerminatedNCT03299842Phase 3
Sponsor listed in the registry: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. · First submitted before Zogenix International Limited, Inc. became part of UCB S.A.
A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet SyndromeCompletedNCT02682927Phase 3
Sponsor listed in the registry: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. · First submitted before Zogenix International Limited, Inc. became part of UCB S.A.
A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet SyndromeCompletedNCT02926898Phase 3
Sponsor listed in the registry: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. · First submitted before Zogenix International Limited, Inc. became part of UCB S.A.